Indivior Pharmaceuticals, Inc. (INDV) · Insider trading
What Indivior Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$311,556
7 insiders, 10 trades
Sold, 12 months
$2.83M
2 insiders, 100% under a plan
Net, 12 months
−$2.52M
bought less sold
Latest filing
2026-08-27
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Heidbreder ChristianChief Scientific Officer | – | $1.47M | 2 | 2026-07-10 | 209,337 |
| Preblick RyanChief Financial Officer | – | $1.36M | 1 | 2026-06-08 | 284,751 |
| Anderson Woodrow DChief Accounting Officer | $107,955 | – | 2 | 2026-08-27 | 27,638 |
| Wheadon David E.Director | $62,676 | – | 1 | 2026-01-05 | 14,395 |
| Kingsley Stuart ADirector | $29,958 | – | 1 | 2026-03-06 | 5,582 |
| Ryan BarbaraDirector | $28,685 | – | 3 | 2026-03-13 | 5,724 |
| Ninivaggi Daniel ADirector | $27,427 | – | 1 | 2026-01-05 | 16,923 |
| Stejbach MarkDirector | $27,427 | – | 1 | 2026-01-05 | 16,847 |
| Humphreys KeithDirector | $27,427 | – | 1 | 2026-01-05 | 5,802 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Anderson Woodrow DChief Accounting Officer | Buy | 1,500 | 35.69 | $53,535 | 27,638 | Form 4 |
| 2026-08-05 | Anderson Woodrow DChief Accounting Officer | Buy | 1,500 | 36.28 | $54,420 | 26,138 | Form 4 |
| 2026-07-10 | Heidbreder ChristianChief Scientific Officer | Saleplan | 18,586 | 41.14 | $764,628 | 209,337 | Form 4 |
| 2026-06-11 | Heidbreder ChristianChief Scientific Officer | Saleplan | 18,586 | 38.06 | $707,383 | 227,923 | Form 4 |
| 2026-06-08 | Preblick RyanChief Financial Officer | Saleplan | 36,000 | 37.70 | $1.36M | 284,751 | Form 4 |
| 2026-03-13 | Ryan BarbaraDirector | Buy | 8 | 31.09 | $249 | 5,724 | Form 4 |
| 2026-03-09 | Ryan BarbaraDirector | Buy | 31 | 32.56 | $1,009 | 5,716 | Form 4 |
| 2026-03-06 | Kingsley Stuart ADirector | Buy | 940 | 31.87 | $29,958 | 5,582 | Form 4 |
| 2026-01-05 | Ninivaggi Daniel ADirector | Buyplan | 775 | 35.39 | $27,427 | 16,923 | Form 4 |
| 2026-01-05 | Stejbach MarkDirector | Buyplan | 775 | 35.39 | $27,427 | 16,847 | Form 4 |
| 2026-01-05 | Wheadon David E.Director | Buyplan | 1,771 | 35.39 | $62,676 | 14,395 | Form 4 |
| 2026-01-05 | Ryan BarbaraDirector | Buyplan | 775 | 35.39 | $27,427 | 1,963 | Form 4 |
| 2026-01-05 | Humphreys KeithDirector | Buyplan | 775 | 35.39 | $27,427 | 5,802 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
20 × grant or award8 × shares withheld for tax7 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-22 | Ciaffoni JosephDirector, Chief Executive Officer | Option exercise M | +1,266,903 | – | 1,402,879 | Form 4 |
| 2026-06-22 | Ciaffoni JosephDirector, Chief Executive Officer | Shares withheld for tax F | −612,549 | 38.32 | 790,330 | Form 4 |
| 2026-05-13 | Ninivaggi Daniel ADirector | Grant or award A | +6,518 | – | 27,163 | Form 4 |
| 2026-05-13 | Kingsley Stuart ADirector | Grant or award A | +6,518 | – | 12,100 | Form 4 |
| 2026-05-13 | Stejbach MarkDirector | Grant or award A | +6,518 | – | 27,087 | Form 4 |
| 2026-05-13 | Thompson JulietDirector | Grant or award A | +6,518 | – | 12,973 | Form 4 |
| 2026-05-13 | Wheadon David E.Director | Grant or award A | +10,430 | – | 30,780 | Form 4 |
| 2026-05-13 | Ryan BarbaraDirector | Grant or award A | +6,518 | – | 12,242 | Form 4 |
| 2026-05-13 | Humphreys KeithDirector | Grant or award A | +6,518 | – | 16,042 | Form 4 |
| 2026-05-12 | Thompson JulietDirector | Shares withheld for tax F | −1,117 | 38.28 | 6,455 | Form 4 |
| 2026-03-14 | Preblick RyanChief Financial Officer | Option exercise M | +6,302 | – | 323,594 | Form 4 |
| 2026-03-14 | Preblick RyanChief Financial Officer | Shares withheld for tax F | −2,843 | 31.11 | 320,751 | Form 4 |
| 2026-03-03 | Burris Jeffrey WChief Legal Officer | Option exercise M | +79,893 | – | 107,550 | Form 4 |
| 2026-03-03 | Burris Jeffrey WChief Legal Officer | Shares withheld for tax F | −36,032 | 31.98 | 71,518 | Form 4 |
| 2026-03-03 | Anderson Woodrow DChief Accounting Officer | Option exercise M | +18,364 | – | 29,657 | Form 4 |
| 2026-03-03 | Anderson Woodrow DChief Accounting Officer | Shares withheld for tax F | −8,283 | 31.98 | 21,374 | Form 4 |
| 2026-03-03 | Anderson Woodrow DChief Accounting Officer | Option exercise M | +5,946 | – | 27,320 | Form 4 |
| 2026-03-03 | Anderson Woodrow DChief Accounting Officer | Shares withheld for tax F | −2,682 | 31.98 | 24,638 | Form 4 |
| 2026-03-03 | Heidbreder ChristianChief Scientific Officer | Option exercise M | +101,544 | – | 292,306 | Form 4 |
| 2026-03-03 | Heidbreder ChristianChief Scientific Officer | Shares withheld for tax F | −45,797 | 31.98 | 246,509 | Form 4 |
| 2026-03-03 | Preblick RyanChief Financial Officer | Shares withheld for tax F | −87,597 | 31.98 | 230,343 | Form 4 |
| 2026-03-03 | Preblick RyanChief Financial Officer | Option exercise M | +86,949 | – | 317,292 | Form 4 |
| 2026-02-10 | Ciaffoni JosephDirector, Chief Executive Officer | Grant or award A | +79,976 | – | 135,976 | Form 4 |
| 2026-02-10 | Burris Jeffrey WChief Legal Officer | Grant or award A | +26,897 | – | 27,657 | Form 4 |
| 2026-02-10 | Barry Patrick AChief Commercial Officer | Grant or award A | +31,380 | – | 31,380 | Form 4 |
| 2026-02-10 | Anderson Woodrow DChief Accounting Officer | Grant or award A | +6,903 | – | 11,293 | Form 4 |
| 2026-02-10 | Heidbreder ChristianChief Scientific Officer | Grant or award A | +33,622 | – | 190,762 | Form 4 |
| 2026-02-10 | Preblick RyanChief Financial Officer | Grant or award A | +37,358 | – | 317,940 | Form 4 |
| 2026-01-26 | Ninivaggi Daniel ADirector | Grant or award A | +3,722 | – | 20,645 | Form 4 |
| 2026-01-26 | Kingsley Stuart ADirector | Grant or award A | +3,722 | – | 4,642 | Form 4 |
| 2026-01-26 | Stejbach MarkDirector | Grant or award A | +3,722 | – | 20,569 | Form 4 |
| 2026-01-26 | Thompson JulietDirector | Grant or award A | +3,722 | – | 7,572 | Form 4 |
| 2026-01-26 | Wheadon David E.Director | Grant or award A | +5,955 | – | 20,350 | Form 4 |
| 2026-01-26 | Ryan BarbaraDirector | Grant or award A | +3,722 | – | 5,685 | Form 4 |
| 2026-01-26 | Humphreys KeithDirector | Grant or award A | +3,722 | – | 9,524 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.